Neuropathic pain.
Conditions
Interventions
Intervention 1: Intervention group: Participants in the intervention group will apply 5 cc of bitter almond oil to their hands up to the elbows and 5 cc to their legs up to the knees three times a da
Sponsors
Kashan University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Willingness to participate in the research Patients undergoing chemotherapy with platinum compounds (cisplatin, oxaliplatin, carboplatin) or taxanes (paclitaxel, docetaxel) or vinca alkaloids (vincristine, vinblastine) DN4 score equal to or greater than 4 No cognitive problems based on the AMT questionnaire score greater than 8 No psychiatric disorders based on self-report from the patient and accompanying person No disabilities or movement disorders Ability to speak Persian No history of type 1 or type 2 diabetes based on self-report from the patient No history of allergy to topical oils and aromatherapy essences based on self-report from the patient
Exclusion criteria
Exclusion criteria: Lack of willingness to continue participation in the research Death or unavailability of the participant Patients with metastasis to soft tissue and bone Not taking medication for 3 consecutive days Development of local allergies or wounds at the intervention site Hospitalization Self-medication with supplements (outside of doctor's orders) for the management of neuropathic pain
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Consequences of neuropathic pain. Timepoint: At the beginning of the study (before the start of the intervention), Day 15 of intervention, the end of the intervention (30 days), one month after the end of the intervention. Method of measurement: Douleur Neuropathique 4 Questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of life. Timepoint: At the beginning of the study (before the start of the intervention), Day 15 of intervention, the end of the intervention (30 days), one month after the end of the intervention. Method of measurement: The European organization for research and treatment of cancer quality of life questionnaire–Chemotherapy-Induced Peripheral Neuropathy 20-Item Scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactIsmail Azizi-Fini
Kashan University of Medical Sciences
Outcome results
None listed